» Articles » PMID: 20812869

Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection

Overview
Specialty Endocrinology
Date 2010 Sep 4
PMID 20812869
Citations 344
Authors
Affiliations
Soon will be listed here.
Abstract

Significant amounts of oxygen free radicals (oxidants) are generated during cerebral ischemia/reperfusion, and oxidative stress plays an important role in brain damage after stroke. In addition to oxidizing macromolecules, leading to cell injury, oxidants are also involved in cell death/survival signal pathways and cause mitochondrial dysfunction. Experimental data from laboratory animals that either overexpress (transgenic) or are deficient in (knock-out) antioxidant proteins, mainly superoxide dismutase, have provided strong evidence of the role of oxidative stress in ischemic brain damage. In addition to mitochondria, recent reports demonstrate that NADPH oxidase (NOX), an important pro-oxidant enzyme, is also involved in the generation of oxidants in the brain after stroke. Inhibition of NOX is neuroprotective against cerebral ischemia. We propose that superoxide dismutase and NOX activity in the brain is a major determinant for ischemic damage/repair and that these major anti- and pro-oxidant enzymes are potential endogenous molecular targets for stroke therapy.

Citing Articles

Glial Cell Reprogramming in Ischemic Stroke: A Review of Recent Advancements and Translational Challenges.

Gresita A, Hermann D, Boboc I, Doeppner T, Petcu E, Semida G Transl Stroke Res. 2025; .

PMID: 39904845 DOI: 10.1007/s12975-025-01331-7.


Neuroprotective effects of phytochemicals through autophagy modulation in ischemic stroke.

Ahmadzadeh A, Pourbagher-Shahri A, Forouzanfar F Inflammopharmacology. 2025; 33(2):729-757.

PMID: 39884996 DOI: 10.1007/s10787-024-01606-9.


EVALUATION OF THE RELATIONSHIP BETWEEN PARAOXONASE-1 ENZYME ACTIVITY, AFFECTED VOLUME, AND STROKE ONSET IN ACUTE ISCHEMIC STROKE PATIENTS.

Atmaca S, Eraybar S, Nennicioglu Y, Yuksel M, Kaya H Acta Clin Croat. 2025; 62(4):627-634.

PMID: 39866766 PMC: 11759118. DOI: 10.20471/acc.2023.62.04.7.


Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity.

Clain J, Couret D, Bringart M, Meilhac O, Lefebvre dHellencourt C, Diotel N IBRO Neurosci Rep. 2025; 18():16-30.

PMID: 39816479 PMC: 11733059. DOI: 10.1016/j.ibneur.2024.12.002.


Chitosan-Based Nanocapsules as a Delivery System of Hydrophobic Carnosic Acid, A Model Neuroprotective Drug.

Odrobinska-Balis J, Procner M, Kruzel K, Regulska M, Leskiewicz M, Duraczynska D Nanotechnol Sci Appl. 2024; 17:259-271.

PMID: 39719965 PMC: 11668332. DOI: 10.2147/NSA.S490372.


References
1.
Barone F, Irving E, Ray A, Lee J, Kassis S, Kumar S . SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther. 2001; 296(2):312-21. View

2.
Jian Liu K, Rosenberg G . Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med. 2005; 39(1):71-80. DOI: 10.1016/j.freeradbiomed.2005.03.033. View

3.
Fujimura M, Kawase M, Copin J, Calagui B, Epstein C, Chan P . Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci. 1999; 19(9):3414-22. PMC: 6782251. View

4.
Luo Y, Kuo C, Shen H, Chou J, Greig N, Hoffer B . Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol. 2009; 65(5):520-30. PMC: 2690614. DOI: 10.1002/ana.21592. View

5.
Keller J, Kindy M, Holtsberg F, St Clair D, Yen H, Germeyer A . Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci. 1998; 18(2):687-97. PMC: 6792529. View